Guidant's ACS to enter angiography market with Torquemaster catheters.
This article was originally published in The Gray Sheet
GUIDANT TO ENTER ANGIOGRAPHY MARKET WITH ACS TORQUEMASTER, a line of angiographic catheters obtained by Guidant unit Advanced Cardiovascular Systems from Adam Spence Corp. in an exclusive distribution agreement announced Feb. 7. Terms of the agreement were not disclosed, but Guidant says the products will be manufactured by Adam Spence and marketed by Guidant's Vascular Intervention group sales force. Torquemaster products, which are pending approval at FDA, are expected to begin entering the market during the first half of 1996, Guidant says.
You may also be interested in...
Will the second wave of coronavirus lockdown have the same impact on the European consumer health industry? Speaking exclusively to HBW Insight from Germany, Merz Consumer Care CEO Frank Baldauf thinks not. Recently investing in premium beard care brand Brooklyn Soap and launching its tetesept Formula range in the Netherlands, Merz's Baldauf suggest that there will be less panic buying this time round and the CHC supply chain will hold up under pressure.
After a strong first quarter, Japan’s Towa Pharmaceuticals saw stability in its domestic revenues but a drop in revenues from its overseas business in its financial second quarter. After launching a series of molecules in June 2020, the company has lined up 10 launches for December 2020 as well.
Pfizer has revealed launch plans for its Nyvepria pegfilgrastim biosimilar, shortly after receiving formal European Commission approval.